Cytology and methylation tests for endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses two simple tests (a cell sample from the uterus and a cervical DNA test) to find endometrial cancer early and to check how well fertility-sparing treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your ultrasound showed a mass or thick lining in the uterus, or you are having follow-up care for early uterine cancer or abnormal cell changes.
- You might be someone receiving treatment for breast cancer that caused the uterine lining to thicken.
- You are not pregnant or recently miscarried, and you do not have active pelvic infections.
- You have not had sexual activity, douching, or used vaginal medicines in the last 24 hours.
- You do not have an intrauterine device (IUD) in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study tests if a DNA test in urine and vaginal samples you collect at home can help find endometrial cancer. It compares results from people with the cancer to healthy volunteers.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This study tests whether a simple vaginal fluid sample can help detect endometrial cancer (cancer of the uterus lining) or precancerous changes. You'll provide a vaginal specimen alongside your standard medical care, helping researchers develop a non-invasive screening tool.
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.